about
Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral LeishmaniasisIdentification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approachA case report of typical leishmaniasis in dogImmunologic indicators of clinical progression during canine Leishmania infantum infectionTreatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum.Use of a LiESP/QA-21 vaccine (CaniLeish) stimulates an appropriate Th1-dominated cell-mediated immune response in dogs.T and B lymphocytes in the brains of dogs with concomitant seropositivity to three pathogenic protozoans: Leishmania chagasi, Toxoplasma gondii and Neospora caninum.Major prospects for exploring canine vector borne diseases and novel intervention methods using 'omic technologiesOne-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasisEvaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.Diagnostic value of conjunctival swab sampling associated with nested PCR for different categories of dogs naturally exposed to Leishmania infantum infection.Are vector-borne pathogen co-infections complicating the clinical presentation in dogs?Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approachImmunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.Immunopathology of leishmaniasis: an update.Immunopathological Features of Canine Myocarditis Associated with Leishmania infantum Infection.A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasisExperimental models in vaccine research: malaria and leishmaniasis.Genome-Wide Association Study of Cell-Mediated Response in Dogs Naturally Infected by Leishmania infantum.Insights on adaptive and innate immunity in canine leishmaniosis.What do we know about feline leishmaniosis?Canine leishmaniasis in Southern Italy: a role for nitric oxide released from activated macrophages in asymptomatic infection?T lymphocytes and macrophages in the intestinal tissues of dogs infected with Leishmania infantum.The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs.Influence of apoptosis on liver and spleen resistance in dogs with visceral leishmaniosis.Detection of intracellular IFN-γ and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum.Detection of Ehrlichia canis, Babesia vogeli, and Toxoplasma gondii DNA in the Brain of Dogs Naturally Infected with Leishmania infantum.Pathology of dogs in Campo Grande, MS, Brazil naturally co-infected with Leishmania infantum and Ehrlichia canis.Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemicFurther evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection.Dog skin parasite load, TLR-2, IL-10 and TNF-α expression and infectiousness.A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.Serological, parasitological and molecular tests for canine visceral leishmaniosis diagnosis in a longitudinal study.Association between canine leishmaniosis and Ehrlichia canis co-infection: a prospective case-control study.Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy.Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control.Vaccines for canine leishmaniasis
P2860
Q27318412-6F623B3A-3EB6-4696-9D08-DFA0EF0F53F4Q28478933-ECC5C23E-6C2F-45EA-AB35-C1293606F9D4Q33423569-3FD4ABA6-7195-46F7-8FE9-E485098A813CQ33627078-4B0834E6-3754-412D-BA40-46EA3E8ABB19Q33870336-F8159E66-FEFE-4C4F-82F4-FA8393A1AD03Q34163466-EE8660EE-D643-42AE-88DF-62704894AC1BQ34298397-68449DCA-ED85-4A59-B438-9FE5D40C3C2BQ34314496-3EC10719-63EA-4FC6-901D-9FCE4452C1E8Q34768379-21701CA1-8578-4E2F-9AC9-600237BE1BCEQ34985660-219FACA1-29D3-4B23-BF54-D5CC5EEB5CEDQ35518943-7993FCEE-10F4-4366-BA20-09C6AA4EDEB8Q35702943-7D6E7D8A-5EC4-4D9A-9EBE-FEB35C841DFEQ36171324-FA0D8082-830B-48E0-B2DC-E2006FD280AFQ36798013-3890C6A3-8B08-4C19-8081-94A30D341812Q36911295-27CC8E15-7E45-4DDF-9F80-9C8C9517DDE4Q36945381-257CCBDC-1C98-41B6-B2C3-79781E7FD536Q36946047-22CB2A83-B89E-4A2C-81EE-2313072953C7Q37060024-1CA5816C-1C1B-42FE-B7E1-E1A26BC26C02Q37144722-6CE3DFB1-39C1-4CFB-976C-70ACD0983200Q37371348-F5540ECB-388F-4EFB-A2EC-C4893C0EEF2EQ37425042-1CB9DF5D-566D-49DB-AD4E-FBF5C0384351Q37605215-11017E34-E069-4D53-B8E8-EA83BE11CA84Q38538909-A471722D-242F-4E7D-A0E0-EB20C9557A81Q38737433-F3ADCB52-E8CF-4455-8D01-A30C0CD6352FQ40118796-326E867F-761D-490A-800D-B1811C3A41A5Q40296327-83CF37C4-BF6A-449E-A119-3F0771E96BC9Q40556477-296B7052-D22A-474F-9492-295EF046A4C7Q40684497-4E299BDF-E7D1-4591-96E2-7E59F614D0BDQ40833843-0DCBBFB5-8A82-4B3D-AEAA-186BC92D661AQ41594777-86DD8F93-E71C-4F32-8D4B-3968E525BFCFQ42046510-03C8384C-DCAA-4F44-8FAD-E9C79E1FD4DCQ42051179-C82715DE-4839-4BDC-ACFD-E9339EBCCB21Q42702134-1ACDB1F1-033D-4B71-B654-8002D2FDFC6AQ43168661-07408610-D8E0-40E4-B9F2-D9ED4B2FB076Q43893585-03312FC1-EFC9-446E-B0E4-F7632FA2E063Q50900191-24AA1A02-2491-4E59-839B-B37A0FCF76AFQ52382222-FC009017-55CD-4D21-8891-4FA268227534Q54965945-CC3FE974-F0FE-4AF4-90E8-850B678DB2F3Q55092035-0687BFAF-8AC2-4575-A72E-B698B6C5F93CQ56769198-E5CBBE25-7DC7-4E2D-A47C-A5BD4930117D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Immunology of canine leishmaniasis.
@ast
Immunology of canine leishmaniasis.
@en
type
label
Immunology of canine leishmaniasis.
@ast
Immunology of canine leishmaniasis.
@en
prefLabel
Immunology of canine leishmaniasis.
@ast
Immunology of canine leishmaniasis.
@en
P2860
P1433
P1476
Immunology of canine leishmaniasis.
@en
P2093
Barbiéri CL
P2860
P304
P356
10.1111/J.1365-3024.2006.00840.X
P577
2006-07-01T00:00:00Z